Valganciclovir Hydrochloride
10 NDCs across 9 manufacturers|10 Generic,0 Brand
Valganciclovir Hydrochloride is used to treat aids-related opportunistic infections and cytomegalovirus retinitis, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Mar 29, 2001, and the first generic was approved Nov 4, 2014. FDA's Orange Book lists 17 AB-rated (therapeutically equivalent) products for this ingredient.
Valganciclovir Hydrochloride is available as 10 NDCs from 9 manufacturers (10 generic, 0 brand), with NADAC prices from $1.01 to $1.33 per ML — a 32% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
10
10G / 0B
Manufacturers
9
competing in market
Price Spread
$1.01 – $1.33
per ML, 7 of 10 NDCs
7d Activity
avg -0.6% WoW · of 10 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Strides Pharma Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
9 manufacturers producing VALGANCICLOVIR HYDROCHLORIDE(2 pricing outliers)
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
VALGANCICLOVIR 450 MG TABLET | $1.9150 per EA | -4.97% |
VALGANCICLOVIR 450 MG TABLET | $1.9150 per EA | -4.97% |
VALGANCICLOVIR 450 MG TABLET | $1.9150 per EA | -4.97% |
VALGANCICLOVIR HCL 50 MG/ML | $1.3267 per ML | — |
VALGANCICLOVIR HCL 50 MG/ML | $1.0058 per ML | +1.62% |
VALGANCICLOVIR HCL 50 MG/ML | $1.0058 per ML | +1.62% |
VALGANCICLOVIR HCL 50 MG/ML | $1.0058 per ML | +1.62% |
VALGANCICLOVIR HCL 50 MG/ML | $1.0058 per ML | +1.62% |
VALGANCICLOVIR HCL 50 MG/ML | $1.0058 per ML | +1.62% |
VALGANCICLOVIR HCL 50 MG/ML | $1.0058 per ML | +1.62% |
Frequently Asked Questions
What is Valganciclovir Hydrochloride used to treat?
Valganciclovir Hydrochloride is used to treat aids-related opportunistic infections and cytomegalovirus retinitis, per the National Library of Medicine's MED-RT classification.
When did Valganciclovir Hydrochloride become available as a generic?
FDA approved the first generic Valganciclovir Hydrochloride (ANDA) on Nov 4, 2014. The Orange Book currently lists 17 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How many Valganciclovir Hydrochloride products are on the market?
The Valganciclovir Hydrochloride drug market contains 10 NDCs from 9 manufacturers — 10 generic and 0 brand products.
What is the price range for Valganciclovir Hydrochloride?
NADAC reference prices for Valganciclovir Hydrochloride range from $1.0058 to $1.3267 per ML — a 32% difference between cheapest and most expensive. 3 additional products are priced per different units (e.g. liquids per ML) and aren't directly comparable.
Which manufacturers make Valganciclovir Hydrochloride?
9 manufacturers list Valganciclovir Hydrochloride in NADAC. Ranked by number of NDCs, the largest are Strides Pharma Inc. (2), Aurobindo Pharma Limited (1), Major Pharmaceuticals (1), American Health Packaging (1), Camber Pharmaceuticals Inc. (1).
How has the price of Valganciclovir Hydrochloride changed recently?
Over the past 7 days, 12 Valganciclovir Hydrochloride NDCs rose and 6 fell, with a market-wide average change of -0.6%.